SLENYTO® is indicated for the treatment of insomnia in children and adolescents aged 2-18 with Autism Spectrum Disorder (ASD) and/or Smith-Magenis syndrome, where sleep hygiene measures have been insufficient.
SLENYTO® is a 3mm diameter film coated mini-tablet that contains the active ingredient, melatonin, a hormone produced naturally by the body.
SLENYTO® is available in two dosage forms – 1 mg prolonged-release melatonin tablets and 5 mg prolonged-release melatonin tablets
SLENYTO® is a prescription-only medicine and should always be used exactly as advised by the doctor or pharmacist.
CIRCADIN® is approved for the short-term treatment of primary insomnia characterized by poor quality of sleep, in patients aged 55 years and older.
CIRCADIN® is a 2mg prolonged-release melatonin tablets
The active substance of Circadin, melatonin, belongs to a natural group of hormones produced by the body.
CIRCADIN® is a prescription-only medicine and should always be taken exactly as advised by the physician or pharmacist.
Through ongoing research and development, we constantly seek to develop innovative, new products, aimed at meeting unmet medical needs.
Click here to learn more about new products currently in Neurim’s pipeline.